Modulation of insulin secretion by diazepam binding inhibitor and its processing products
- 31 December 1991
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 30 (12) , 1399-1403
- https://doi.org/10.1016/s0028-3908(11)80008-0
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Immunohistochemical localization of porcine diazepam-binding inhibitor (DBI) to rat endocrine pancreasCell and tissue research, 1991
- Distribution and characterization of diazepam binding inhibitor (DBI) in peripheral tissues of ratRegulatory Peptides, 1990
- Effects of porcine diazepam-binding inhibitor on insulin and glucagon secretion in vitro from the rat endocrine pancreasRegulatory Peptides, 1990
- Isolation and Characterization of a Rat Brain Triakontatetraneuropeptide, a Posttranslational Product of Diazepam Binding Inhibitor: Specific Action at the Ro 5‐4864 Recognition SiteJournal of Neurochemistry, 1989
- Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channelsNature, 1989
- Identification of des-(Gly-Ile)-endozepine as an effector of corticotropin-dependent adrenal steroidogenesis: stimulation of cholesterol delivery is mediated by the peripheral benzodiazepine receptor.Proceedings of the National Academy of Sciences, 1989
- Isolation and characterization of porcine diazepam‐binding inhibitor, a polypeptide not only of cerebral occurrence but also common in intestinal tissues and with effects on regulation of insulin releaseEuropean Journal of Biochemistry, 1988
- Galanin and the endocrine pancreasFEBS Letters, 1988
- A diazepam binding inhibitor (DBI)-like neuropeptide is detected in human brainBrain Research, 1986
- Diazepam-Binding Inhibitor: A Neuropeptide Located in Selected Neuronal Populations of Rat BrainScience, 1985